Active substance
Results for the substance dupilumab
4 results
About this active substance
Dupilumab is a medication used for the treatment of moderate to severe atopic dermatitis, eosinophilic asthma, and chronic allergic rhinitis. It is a monoclonal antibody that blocks receptors for interleukins 4 and 13, reducing inflammation and associated symptoms.
The medication is administered as a subcutaneous injection, usually once every two weeks, according to the doctor's instructions. It is effective in alleviating symptoms and improving patients' quality of life.
Side effects may include injection site reactions, conjunctivitis, headache, and, in rare cases, severe allergic reactions. Regular monitoring is recommended during treatment.
Consult your doctor to discuss the benefits and risks of treatment with Dupilumab. Follow the administration instructions to ensure therapy effectiveness.
The medication is administered as a subcutaneous injection, usually once every two weeks, according to the doctor's instructions. It is effective in alleviating symptoms and improving patients' quality of life.
Side effects may include injection site reactions, conjunctivitis, headache, and, in rare cases, severe allergic reactions. Regular monitoring is recommended during treatment.
Consult your doctor to discuss the benefits and risks of treatment with Dupilumab. Follow the administration instructions to ensure therapy effectiveness.
-
-
DUPIXENT 200mg 175mg/ml solution for injection in pre-filled pen SANOFI ORIGINAL MEDICINE
-
DUPIXENT 200mg 175mg/ml solution for injection in pre-filled syringe SANOFI ORIGINAL MEDICINE
-
DUPIXENT 300mg 150mg/ml solution for injection in pre-filled syringe SANOFI ORIGINAL MEDICINE